Competition & Peer Data API & CSV Delivery

Intersect Ent Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Intersect Ent Inc (XENT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2022
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-11.32 %
Q1 2022
Net Margin
-267.01 %
Q1 2022

Key Findings: Intersect Ent Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 104M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-17.0% annualized vs trailing 12 months).
  • Peer revenue share: Intersect Ent Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

XENT Sales vs. its Competitors, Q1 2022

Intersect Ent Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/XENT/competitors
https://api.csimarket.com/api/v1/companies/XENT/relationships
https://api.csimarket.com/api/v1/companies/XENT/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs -11.3% for Intersect Ent Inc. Intersect Ent Inc's share of combined industry revenue moved from 0.02% to 0.02%, a loss of 0.01 percentage points.

Intersect Ent Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Intersect Ent Inc No Yes Yes No
Similar Growth & Profitability (8) 0.00 % (0 of 8) 62.50 % (5 of 8) 62.50 % (5 of 8) 28.60 % (2 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2022

100%market share
  • Intersect Ent Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Intersect Ent Inc and its 0 tracked competitors.

See Intersect Ent Inc's full market share breakdown »

XENT Stock Performance relative to its Competitors

XENT Competitors (weighted) Percent change over the selected range

XENT Stock Performance relative to Similar Growth & Profitability Competitors

XENT Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range